PIK3CA and neoplasm: In GC cells, mutations in the GTP binding domain lead to sustained activation of RAS [48] and downstream PI3K/AKT/mTOR pathway, thereby promoting tumor growth and resistance to apoptosis [40] (circle marked 5 in Fig. 3).